Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

OM PHARMA, S.A.

NIF 500207410
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €1,561,284 48 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €1,561,284 48 contracts
A2 · Late Publication €1,085,503,928 623 contracts
Contract published to BASE more than 10 days after the signing date
LOW €1,085,503,928 623 contracts
A5 · Threshold Splitting €1,159,712 21 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,159,712 21 contracts
A9 · Abnormal Price Reduction €1,581,885,850 311 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €1,581,885,850 311 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

21
€92,890,042
36
€90,142,487
13
€84,580,741
98
€81,914,438
11
€72,615,844
11
€72,540,060
30
€71,783,359
18
€71,524,535
5
€70,753,743
51
€70,077,120
44
€69,486,011
5
€67,159,323
7
€65,816,014
3
€64,895,218
6
€64,848,857
6
€57,157,552
3
€50,195,840
7
€50,184,180
2
€46,901,044
12
€42,033,150
Page 1 of 3 · 56 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A9 · Abnormal Price Reduction

Page 1 of 1 · 21 contracts

FERRO (CARBOXIMALTOSE) 500 MG/10ML SOL INJ FR IV -FERINJECT
PT · 9203039 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€74,043 2022-02-10
Aquisição de medicamentos do grupo 4: sangue ao abrigo do Acordo Quadro 2020/18
PT · 9250329 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€145,003 2021-04-28
2021002242 - Fe Carboximaltose ferrica 50 mg/ml Sol inj Fr 10 ml IV
PT · 7856056 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,936 2021-02-17
VARIOS MEDICAMENTOS
PT · 7465556 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,502 2021-02-08
Q1/2645/2020 Medicamento do grupo 4:Sangue
PT · 6975963 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€143,164 2020-09-16
MEDICAMENTOS
PT · 6974844 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€72,458 2020-09-01
AQUISIÇÃO DE CARBOXIMALTOSE + HEPARINA + PEGFILGRASTIM
PT · 7230217 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,282 2020-08-27
MEDICAMENTOS
PT · 6777088 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€74,078 2020-07-07
MEDICAMENTOS
PT · 788a0aebf01f11beeed9 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,742 2020-07-07
MEDICAMENTOS APARELHO DIGESTIVO
PT · 7340051 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€4,913 2020-03-12
Diversos Medicamentos
PT · 6202051 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,810 2019-11-29
Q1/1753/2019 Medicamentos do Grupo 4: Sangue
PT · 6099289 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€147,256 2019-11-25
AQUISIÇÃO DE OXIHIDRÓXIDO SUCROFÉRRICO 500 MG COMP MAST
PT · 6586279 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,864 2019-07-15
O presente procedimento tem por objeto a aquisição dos bens acima identificados, para o CHPVVC,E.P.E.
PT · 4387398 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,191 2018-02-06
51005218 - Medicamentos SPMS
PT · 4571379 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€4,929 2018-01-22
01000217 - Fornecimento de medicamentos consumo Geral - Grupo 4 - Sangue
PT · 764232289dd76b34bc5a · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,326 2017-03-27
FI0016/2017 - MEDICAMENTOS DO GRUPO 4 SANGUE
PT · 4140551 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€143,822 2017-01-20
51000117 - MEDICAMENTOS C/ CHNM
PT · 4072885 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,123 2017-01-16
FERRO (CARBOXIMALTOSE) 500 MG/10ML SOL INJ FR IV -FERINJECT - Ajuste Directo nº 11183116
PT · 2650684 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,076 2016-07-01
E AD20150125 - ANTIEMETICOS E ANTIVERTIGINOSOS 2016
PT · 2054472 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€73,425 2016-02-11
AD para Aquisição de Carboximaltose férrica 50 mg/ ml sol inj fr 10 ml IV
PT · 1489242 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,769 2015-02-27
Overview
Total Value Won
€1,599,337,191
Contracts Won
816
Score 31165 · CRITICAL RISK
NIF
500207410
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.S. [P-b17a]
    Presidente
    since 2011-06-03
  • A.S. [P-b17a]
    Presidente
    since 2016-12-06
  • A.S. [P-b17a]
    Presidente
    since 2014-02-26
  • D.C. [P-3ae3]
    Administrador
    since 2015-03-09
  • G.M. [P-e646]
    Vogal
    since 2018-06-20
  • M.S. [P-f555]
    Presidente
    since 2022-02-08
  • N.D. [P-acc1]
    Vogal
    since 2025-01-07
  • O.P. [P-4a80]
    Vogal
    since 2011-06-03
  • O.P. [P-4a80]
    Vogal
    since 2014-02-26
  • S.M. [P-943e]
    Vogal
    since 2018-06-20
  • T.R. [P-fa92]
    Administrador
    since 2012-10-24
  • A.G. [P-5511]
    Fiscal Único
    since 2016-01-07
  • A.G. [P-5511]
    Fiscal Único
    since 2016-12-06
  • C.P. [P-2dd6]
    Fiscal Único
    since 2014-02-26
  • E.Y. [P-6b36]
    Fiscal Único
    since 2020-03-16
  • E.Y. [P-6b36]
    Fiscal Único
    since 2023-04-13
  • L.M. [P-2cbf]
    Fiscal Único
    since 2020-03-16
  • L.M. [P-2cbf]
    Fiscal Único
    since 2023-04-13
  • M.S. [P-3fb7]
    Fiscal Único
    since 2016-01-07
  • M.S. [P-3fb7]
    Fiscal Único
    since 2016-12-06
  • S.P. [P-b833]
    Fiscal Único
    since 2011-06-03
  • A.S. [P-b17a]
    Vogal
    2020-03-16 → 2022-02-08
  • D.C. [P-3ae3]
    Vogal
    2016-12-06 → 2018-06-20
  • G.M. [P-e646]
    Vogal
    2020-03-16 → 2022-02-08
  • H.S. [P-f6ef]
    Vogal
    2022-02-08 → 2024-02-21
  • J.A. [P-04a9]
    Administrador
    2021-03-26 → 2022-02-08
  • L.H. [P-8e9d]
    Vogal
    2022-02-08 → 2025-01-07
  • M.U. [P-c7b2]
    Vogal
    2011-06-03 → 2012-10-24
  • O.P. [P-4a80]
    Vogal
    2016-12-06 → 2018-06-20
  • S.M. [P-943e]
    Vogal
    2020-03-16 → 2021-03-26
  • T.R. [P-fa92]
    Vogal
    2014-02-26 → 2015-03-09
  • C.P. [P-2dd6]
    Fiscal Único
    2011-06-03 → 2016-01-07
  • S.P. [P-b833]
    Fiscal Único
    2014-02-26 → 2016-01-07
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned